Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,779,938
-
Total 13F shares
-
53,537,579
-
Share change
-
+223,593
-
Total reported value
-
$1,092,709,410
-
Put/Call ratio
-
81%
-
Price per share
-
$20.41
-
Number of holders
-
104
-
Value change
-
+$7,301,237
-
Number of buys
-
40
-
Number of sells
-
50
Institutional Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q1 2021
As of 31 Mar 2021 Theravance Biopharma, Inc. - Common Stock (TBPH) had 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 53,537,579 shares of stock of the company.
Largest 10 holders included FMR LLC, BAUPOST GROUP LLC/MA, WELLINGTON MANAGEMENT GROUP LLP, ORBIMED ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Chescapmanager LLC, GEODE CAPITAL MANAGEMENT, LLC, and Laurion Capital Management LP.
This table shows 104 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.